Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04213599
Other study ID # 9215443693
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2011
Est. completion date September 30, 2020

Study information

Verified date December 2019
Source Xiamen Cardiovascular Hospital, Xiamen University
Contact Bin Wang, PhD
Phone +8613400664305
Email mocw361@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To analyze whether the location of myocardial infarction and infarct related artery are related to FWR.


Description:

To know the characteristic of FWR that different location of STEMI and coronary distribution


Recruitment information / eligibility

Status Recruiting
Enrollment 14629
Est. completion date September 30, 2020
Est. primary completion date August 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Patients had to be =18 years of age, be admitted for STEMI

2. Accord with STEMI diagnostic criteria

3. STEMI patients anticipated to undergo angiography

Exclusion Criteria:

1. Pregnant

2. Acute stroke

3. Aortic dissection

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Coronary intervention
Patients with STEMI undergo coronary intervention

Locations

Country Name City State
China Xiamen Cardiovascular Hospital Xiamen University Xiamen Fujian

Sponsors (1)

Lead Sponsor Collaborator
Xiamen Cardiovascular Hospital, Xiamen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of cardiac death In-hospital cardiac death during 30 days 30 days
Primary Number of free-wall rupture The FWR after STEMI patients 30 days
Primary Number of reperfusion arrhythmia Reperfusion arrhythmia during coronary intervention 30 days
Secondary FMC time First Medical Contact time 30 days
Secondary Symptom onset to angiology time The time from symptom onset to beginning of angiography 30 days
See also
  Status Clinical Trial Phase
Completed NCT01864343 - Target Temperature Management In Myocardial Infarction - A Pilot Study N/A
Completed NCT00962416 - Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction (STEMI) Phase 4
Active, not recruiting NCT00927615 - Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO) N/A
Completed NCT03135275 - MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial N/A
Recruiting NCT02592694 - Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Phase 4
Withdrawn NCT01991366 - Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?
Completed NCT02158468 - Effect of Conditioning on Myocardial Damage in STEMI N/A
Completed NCT01197729 - OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry N/A
Completed NCT06426537 - Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches Early Phase 1
Completed NCT01882179 - Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size Phase 3
Terminated NCT00719914 - A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks Phase 2
Completed NCT00952224 - Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome N/A
Completed NCT00378391 - European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry N/A
Withdrawn NCT04303377 - Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction Phase 2
Completed NCT03523624 - Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction
Completed NCT01531114 - PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus Phase 3
Active, not recruiting NCT01960933 - Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization N/A
Completed NCT00502528 - Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction Phase 2
Recruiting NCT02062554 - Brasilia Heart Study
Recruiting NCT04150016 - In-stent Repair and Vessel Reaction of STEMI Patients With OCT N/A